glp-1 peptide Compounded - Semaglutide & Tirzepatide Structure-Based Discovery of Orthosteric Non-Peptide

You're curious about GLP-1s but not ready to jump to a full dose

Read the full story here To view or add a comment, sign in One of the most interesting recent developments in the pharmaceutical industry is the patent expiry of Semaglutide in India (March 2026) , which may significantly improve access to advanced diabetes and obesity treatments

Tendon healing In a rat model in the Journal of Applied Physiology , BPC-157 accelerated tendon healing by promoting tendon-cell outgrowth, cell survival and cell migration, which the authors linked to the VEGF and nitric-oxide pathways [2]

doi: 10.1139/bcb-2021-0365 43 BudakMachnikGBudakRJabuzekKBodysABelowskiDet al